Endo International
Ireland-domiciled pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Endo Pharmaceuticals?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system.[2][3][4]
More information Region, Sales ($ m) ...
Region | Sales ($ m) | Distribution (%) |
---|---|---|
U.S. Generic | 2,281.0 | 65.8 |
U.S. Branded | 957.5 | 27.6 |
Non-U.S. / International | 230.3 | 6.6 |
Total | 3,468.8 | 100.0 |
Close
Quick Facts Company type, Traded as ...
Company type | public liability company |
---|---|
Expert Market: ENDPQ | |
ISIN | IE00BJ3V9050 |
Industry | Pharmaceutical |
Predecessor | Endo Pharmaceuticals Inc. (before the 2014 tax inversion to Ireland) |
Founded | 1997; 27 years ago (1997) |
Headquarters |
|
Key people | |
Revenue | |
Total assets | |
Number of employees | 3103 (2021)[1]: 16 |
Website | endo |
Footnotes / references Financials[1]: F-6, 7 |
Close